The use of bronchodilator drugs to reduce the symptoms and increase the exercise
tolerance of patients with chronic obstructive pulmonary disease (COPD) is a cornerstone of …

Bronchodilators remain the mainstay of chronic obstruc-tive pulmonary disease (COPD)
management and are recommended for the treatment of symptomatic patients at all stages …

Although the main characteristic of chronic obstructive pulmonary disease (COPD) is
relentlessly worsening airflow limitation, many patients show some degree of reversibility …

ilation of spirometry, IOS and body plethysmography in patients with COPD. They found that,
although spirometry is more reproducible than IOS and body plethysmography, total …

Bronchodilator therapy in COPD is deemed successful if it improves ventilatory mechanics to
a degree where effective symptom alleviation and increased exercise capacity are achieved …

Partial bronchodilator reversibility can be demonstrated in many patients with stable chronic
obstructive pulmonary disease (COPD), but its relevance to exercise capacity and symptoms …

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide. Developments in the understanding of COPD have led to standard guidelines for …

Chronic obstructive pulmonary disease (COPD) is a treatable disease characterized by
progressive airflow limitation. Prevention of disease progression, improvement of symptoms …

This paper reviews new developments in bronchodilator therapy for chronic obstructive
pulmonary disease (COPD). Most patients with COPD respond to bronchodilators, but we …

The long-acting inhaled bronchodilators available for use in chronic obstructive pulmonary
disease (COPD) vary in their pharmacological class (β 2-adrenergic agonist or …